The Paramyxovirus Fusion Protein C-Terminal Region: Mutagenesis Indicates an Indivisible Protein Unit

Zokarkar, Aarohi; Lamb, Robert A.

doi:10.1128/jvi.06546-11

Cited by 18 publications

(20 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies of the CTDs of paramyxovirus fusion proteins and the HSV-1 gB CTD, as well as our study of the EBV gB CTD, indicate that this domain has an important regulatory role in fusion activation. Both hyperfusogenic and hypofusogenic mutations can be found within the CTD (22,(43)(44)(45)(46)(47)(48)(49). A recent study with the HSV-1 gB CTD suggests that the hyperfusion phenotype is associated with diminished membrane interactions (29).…”

Section: Discussionmentioning

confidence: 99%

The Epstein-Barr Virus (EBV) Glycoprotein B Cytoplasmic C-Terminal Tail Domain Regulates the Energy Requirement for EBV-Induced Membrane Fusion

Chen

Zhang

Jardetzky

et al. 2014

J Virol

View full text Add to dashboard Cite

The entry of enveloped viruses into host cells is preceded by membrane fusion, which in Epstein-Barr virus (EBV) is thought to be mediated by the refolding of glycoprotein B (gB) from a prefusion to a postfusion state. In our current studies, we characterized a gB C-terminal tail domain (CTD) mutant truncated at amino acid 843 (gB843). This truncation mutant is hyperfusogenic as monitored by syncytium formation and in a quantitative fusion assay and is dependent on gH/gL for fusion activity. gB843 can rescue the fusion function of other glycoprotein mutants that have null or decreased fusion activity in epithelial and B cells. In addition, gB843 requires less gp42 and gH/gL for fusion, and can function in fusion at a lower temperature than wild-type gB, indicating a lower energy requirement for fusion activation. Since a key step in fusion is the conversion of gB from a prefusion to an active postfusion state by gH/gL, gB843 may access this activated gB state more readily. Our studies indicate that the gB CTD may participate in the fusion function by maintaining gB in an inactive prefusion form prior to activation by receptor binding. IMPORTANCE Diseases resulting from Epstein-Barr virus (EBV) infection in humans range from the fairly benign disease infectious mononu-cleosis to life-threatening cancer. As an enveloped virus, EBV must fuse with a host cell membrane for entry and infection by using glycoproteins gH/gL, gB, and gp42. Among these glycoproteins, gB is thought to be the protein that executes fusion. To further characterize the function of the EBV gB cytoplasmic C-terminal tail domain (CTD) in fusion, we used a previously constructed CTD truncation mutant and studied its fusion activity in the context of other EBV glycoprotein mutants. From these studies, we find that the gB CTD regulates fusion by altering the energy requirements for the triggering of fusion mediated by gH/gL or gp42. Overall, our studies may lead to a better understanding of EBV fusion and entry, which may result in novel therapies that target the EBV entry step.

show abstract

Section: Discussionmentioning

confidence: 99%

The Epstein-Barr Virus (EBV) Glycoprotein B Cytoplasmic C-Terminal Tail Domain Regulates the Energy Requirement for EBV-Induced Membrane Fusion

Chen

Zhang

Jardetzky

et al. 2014

J Virol

View full text Add to dashboard Cite

show abstract

“…A transmembrane domain (TM) and a cytoplasmic tail (CT) are located at the C-terminal end of the F 1 subunit. During viral assembly, the CT is thought to interact with internal virion proteins to mediate packaging of the F protein into virions (16)(17)(18). Evidence from several paramyxoviruses implicated TM and CT in modulating fusogenic activity, stability, and protein folding (17,19).…”

mentioning

confidence: 99%

Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector

Liang

Ngwuta

Herbert

et al. 2016

J Virol

View full text Add to dashboard Cite

Human respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (HPIV3) are major pediatric respiratory pathogens that lack vaccines. A chimeric bovine/human PIV3 (rB/HPIV3) virus expressing the unmodified, wild-type (wt) RSV fusion (F) protein from an added gene was previously evaluated in seronegative children as a bivalent intranasal RSV/HPIV3 vaccine, and it was well tolerated but insufficiently immunogenic for RSV F. We recently showed that rB/HPIV3 expressing a partially stabilized prefusion form (pre-F) of RSV F efficiently induced "high-quality" RSV-neutralizing antibodies, defined as antibodies that neutralize RSV in vitro without added complement (B. Liang et al., J Virol 89:9499 -9510, 2015, doi:10.1128/JVI.01373-15). In the present study, we modified RSV F by replacing its cytoplasmic tail (CT) domain or its CT and transmembrane (TM) domains (TMCT) with counterparts from BPIV3 F, with or without pre-F stabilization. This resulted in RSV F being packaged in the rB/HPIV3 particle with an efficiency similar to that of RSV particles. Enhanced packaging was substantially attenuating in hamsters (10-to 100-fold) and rhesus monkeys (100-to 1,000-fold). Nonetheless, TMCT-directed packaging substantially increased the titers of high-quality RSV-neutralizing serum antibodies in hamsters. In rhesus monkeys, a strongly additive immunogenic effect of packaging and pre-F stabilization was observed, as demonstrated by 8-and 30-fold increases of RSV-neutralizing serum antibody titers in the presence and absence of added complement, respectively, compared to pre-F stabilization alone. Analysis of vaccine-induced F-specific antibodies by binding assays indicated that packaging conferred substantial stabilization of RSV F in the pre-F conformation. This provides an improved version of this well-tolerated RSV/HPIV3 vaccine candidate, with potently improved immunogenicity, which can be returned to clinical trials. IMPORTANCEHuman respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (HPIV3) are major viral agents of acute pediatric bronchiolitis and pneumonia worldwide that lack vaccines. A bivalent intranasal RSV/HPIV3 vaccine candidate consisting of a chimeric bovine/human PIV3 (rB/HPIV3) strain expressing the RSV fusion (F) protein was previously shown to be well tolerated by seronegative children but was insufficiently immunogenic for RSV F. In the present study, the RSV F protein was engineered to be packaged efficiently into vaccine virus particles. This resulted in a significantly enhanced quantity and quality of RSV-neutralizing antibodies in hamsters and nonhuman primates. In nonhuman primates, this effect was strongly additive to the previously described stabilization of the prefusion conformation of the F protein. The improved immunogenicity of RSV F by packaging appeared to involve prefusion stabilization. These findings provide a potently more immunogenic version of this welltolerated vaccine candidate and should be applicable to other vectored vaccines.

show abstract

“…For example, replacing the TMDs of parainfluenza virus 5 (PIV5) and Newcastle disease virus fusion proteins with comparable domains of other paramyxovirus fusion proteins altered the ectodomain structure and reduced fusion, indicating site-specific interactions between the ectodomain and the TMD (18,19). Various studies also suggested that the TMDs may modulate membrane curvature.…”

mentioning

confidence: 99%

Viral fusion protein transmembrane domain adopts β-strand structure to facilitate membrane topological changes for virus–cell fusion

Yao

Lee

Waring

et al. 2015

Proc. Natl. Acad. Sci. U.S.A.

View full text Add to dashboard Cite

The C-terminal transmembrane domain (TMD) of viral fusion proteins such as HIV gp41 and influenza hemagglutinin (HA) is traditionally viewed as a passive α-helical anchor of the protein to the virus envelope during its merger with the cell membrane. The conformation, dynamics, and lipid interaction of these fusion protein TMDs have so far eluded high-resolution structure characterization because of their highly hydrophobic nature. Using magicangle-spinning solid-state NMR spectroscopy, we show that the TMD of the parainfluenza virus 5 (PIV5) fusion protein adopts lipid-dependent conformations and interactions with the membrane and water. In phosphatidylcholine (PC) and phosphatidylglycerol (PG) membranes, the TMD is predominantly α-helical, but in phosphatidylethanolamine (PE) membranes, the TMD changes significantly to the β-strand conformation. Measured order parameters indicate that the strand segments are immobilized and thus oligomerized. 31 P NMR spectra and small-angle X-ray scattering (SAXS) data show that this β-strand-rich conformation converts the PE membrane to a bicontinuous cubic phase, which is rich in negative Gaussian curvature that is characteristic of hemifusion intermediates and fusion pores. 1 H-31 P 2D correlation spectra and 2 H spectra show that the PE membrane with or without the TMD is much less hydrated than PC and PG membranes, suggesting that the TMD works with the natural dehydration tendency of PE to facilitate membrane merger. These results suggest a new viral-fusion model in which the TMD actively promotes membrane topological changes during fusion using the β-strand as the fusogenic conformation.solid-state NMR spectroscopy | small-angle X-ray scattering | conformational polymorphism | membrane curvature | peptide-membrane interactions V iral fusion proteins mediate entry of enveloped viruses into cells by merging the viral lipid envelope and the cell membrane. The membrane-interacting subunit of these glycoproteins contains two hydrophobic domains: a fusion peptide (FP) that is usually located at the N terminus and a transmembrane domain (TMD) at the C terminus (1). Together, these domains sandwich a water-soluble ectodomain with a helical segment that trimerizes into a coiled coil. During virus-cell fusion, the trimeric protein, which initially adopts a compact structure, unfolds to an extended intermediate that exposes the FP to the target cell membrane while keeping the TMD in the virus envelope. This extended conformation then folds onto itself to form a trimer of hairpins, in so doing pulling the cell membrane and the virus envelope into close proximity (2, 3). Subsequently, the FP and TMD are hypothesized to deform the two membranes and dehydrate them (4), eventually causing a fusion pore and a fully merged membrane. In the postfusion state, most viral fusion proteins exhibit a six-helixbundle structure in the ectodomain due to the trimer of hairpins (5).This model of virus-cell fusion largely derives from crystal structures of fusion proteins in the pre-and postfusion st...

show abstract

The Paramyxovirus Fusion Protein C-Terminal Region: Mutagenesis Indicates an Indivisible Protein Unit

Cited by 18 publications

References 54 publications

The Epstein-Barr Virus (EBV) Glycoprotein B Cytoplasmic C-Terminal Tail Domain Regulates the Energy Requirement for EBV-Induced Membrane Fusion

The Epstein-Barr Virus (EBV) Glycoprotein B Cytoplasmic C-Terminal Tail Domain Regulates the Energy Requirement for EBV-Induced Membrane Fusion

Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector

Viral fusion protein transmembrane domain adopts β-strand structure to facilitate membrane topological changes for virus–cell fusion

Contact Info

Product

Resources

About